These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16402125)

  • 1. Drug metabolism and pharmacogenetics: the British contribution to fields of international significance.
    Caldwell J
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S89-99. PubMed ID: 16402125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics).
    Ozdemir V; Endrenyi L; Aynacıoğlu S; Bragazzi NL; Dandara C; Dove ES; Ferguson LR; Geraci CJ; Hafen E; Kesim BE; Kolker E; Lee EJ; Llerena A; Nacak M; Shimoda K; Someya T; Srivastava S; Tomlinson B; Vayena E; Warnich L; Yaşar U
    OMICS; 2014 Apr; 18(4):211-21. PubMed ID: 24649998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How personalized medicine became genetic, and racial: Werner Kalow and the formations of pharmacogenetics.
    Jones DS
    J Hist Med Allied Sci; 2013 Jan; 68(1):1-48. PubMed ID: 21908852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics: from description to prediction.
    Weber WW
    Clin Lab Med; 2008 Dec; 28(4):499-511. PubMed ID: 19059058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.
    Nebert DW; Zhang G; Vesell ES
    Drug Metab Rev; 2008; 40(2):187-224. PubMed ID: 18464043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milestones in clinical pharmacology. Clinical relevance of pharmacogenetics rediscovered.
    Balant LP; Balant-Gorgia AE
    Clin Ther; 1992; 14(2):328-30; discussion 327. PubMed ID: 1611653
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives in pharmacogenetics.
    Kalow W
    Arch Pathol Lab Med; 2001 Jan; 125(1):77-80. PubMed ID: 11151057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The drugs don't work: expectations and the shaping of pharmacogenetics.
    Hedgecoe A; Martin P
    Soc Stud Sci; 2003 Jun; 33(3):327-64. PubMed ID: 14621671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics - five decades of therapeutic lessons from genetic diversity.
    Meyer UA
    Nat Rev Genet; 2004 Sep; 5(9):669-76. PubMed ID: 15372089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Drug reactions, enzymes, and biochemical genetics': 50 years later.
    Gurwitz D; Motulsky AG
    Pharmacogenomics; 2007 Nov; 8(11):1479-84. PubMed ID: 18034611
    [No Abstract]   [Full Text] [Related]  

  • 11. From the Origins of Pharmacogenetics to First Applications in Psychiatry.
    Müller DJ; Rizhanovsky Z
    Pharmacopsychiatry; 2020 Jul; 53(4):155-161. PubMed ID: 31546266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theragnostics--a silent revolution.
    Grigoriu BD
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):7-8. PubMed ID: 25970935
    [No Abstract]   [Full Text] [Related]  

  • 13. The First 50 Years of Molecular Pharmacology.
    Brown JH; Catterall WA; Conn PJ; Cull-Candy SG; Dingledine R; Harden TK; Insel PA; Milligan G; Traynelis SF
    Mol Pharmacol; 2015 Jul; 88(1):139-40. PubMed ID: 25943115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Getting personal.
    Nat Rev Drug Discov; 2007 Aug; 6(8):587. PubMed ID: 17821825
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomics: history, barriers, and regulatory solutions.
    Blankstein S
    Food Drug Law J; 2014; 69(2):273-314, ii. PubMed ID: 25163212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The state of British medicine. 5. The innovation, benefits, drawbacks and control of drugs.
    Dunlop D
    J R Soc Med; 1978 May; 71(5):324-30. PubMed ID: 349154
    [No Abstract]   [Full Text] [Related]  

  • 17. From pharmacogenetics and ecogenetics to pharmacogenomics.
    Motulsky A
    Med Secoli; 2002; 14(3):683-705. PubMed ID: 14650398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of pharmacogenomics for drug development.
    Kirk RJ; Hung JL; Horner SR; Perez JT
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pharmacogenomics: the development of a science.
    Kalow W
    Hum Genomics; 2004 Aug; 1(5):375-80. PubMed ID: 15588498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chapter 30: historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():445-76. PubMed ID: 19892133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.